Daisy Genomics is an Albuquerque-based startup building technology for precision medicine. The company’s platform focuses on leveraging genomic information to tailor medical treatments to individual patients. Though still early stage, Daisy Genomics has attracted investor attention for its potential to advance personalized healthcare. The firm recently secured seed financing to accelerate product development and expand its scientific and engineering team. No operating metrics such as revenue, user count, or customer numbers have been disclosed. The new capital will support continued R&D and go-to-market preparations as the company refines its precision medicine offerings.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Dec 2025